Lucas Mose

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 8

Top Topics

Radical Prostatectomy

Top Venues

Prostate cancer and prostatic diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Ali Janbain, Andrea Farolfi, Armelle Arnoux, Louis Romengas, Sophia Scharl, Stefano Fanti, Francesca Serani, Jan C Peeken, Sandrine Katsahian, Iosif Strouthos, Konstantinos Ferentinos, Stefan A Koerber, Marco M E Vogel, Stephanie Elisabeth Combs, Alexis Vrachimis, Alessio Giuseppe Morganti, Simon K B Spohn, Anca-Ligia Grosu, Francesco Ceci, Christoph Henkenberens, Stephanie G C Kroeze, Matthias Guckenberger, Claus Belka, Peter Bartenstein, George Hruby, Louise Emmett, Ali Afshar Omerieh, Nina-Sophie Schmidt-Hegemann, Lucas Mose, Daniel Matthias Aebersold, Constantinos Zamboglou, Thomas Wiegel, Mohamed Shelan
A Machine Learning Approach for Predicting Biochemical Outcome After PSMA-PET-Guided Salvage Radiotherapy in Recurrent Prostate Cancer After Radical Prostatectomy: Retrospective Study. JMIR cancer 10 (2024)
Mohamed Shelan, Vérane Achard, Felix Appiagyei, Lucas Mose, Thomas Zilli, Christian D Fankhauser, Constantinos Zamboglou, Osama Mohamad, Daniel Matthias Aebersold, Richard Cathomas
Role of enzalutamide in primary and recurrent non-metastatic hormone sensitive prostate cancer: a systematic review of prospective clinical trials. Prostate cancer and prostatic diseases 27 (3) (2024)
Mohamed Shelan, Vérane Achard, Felix Appiagyei, Lucas Mose, Thomas Zilli, Christian D Fankhauser, Constantinos Zamboglou, Osama Mohamad, Daniel Matthias Aebersold, Richard Cathomas
Role of enzalutamide in primary and recurrent non-metastatic hormone sensitive prostate cancer: a systematic review of prospective clinical trials. Prostate cancer and prostatic diseases 27 (3) (2024)
Mohamed Shelan, Vérane Achard, Felix Appiagyei, Lucas Mose, Thomas Zilli, Christian D Fankhauser, Constantinos Zamboglou, Osama Mohamad, Daniel Matthias Aebersold, Richard Cathomas
Role of enzalutamide in primary and recurrent non-metastatic hormone sensitive prostate cancer: a systematic review of prospective clinical trials. Prostate cancer and prostatic diseases (2024)
Mohamed Shelan, Vérane Achard, Felix Appiagyei, Lucas Mose, Thomas Zilli, Christian D Fankhauser, Constantinos Zamboglou, Osama Mohamad, Daniel Matthias Aebersold, Richard Cathomas
Role of enzalutamide in primary and recurrent non-metastatic hormone sensitive prostate cancer: a systematic review of prospective clinical trials. Prostate cancer and prostatic diseases 27 (3) (2024)
Christina Schröder, Lucas Mose, Etienne Mathier, Daniel Rudolf Zwahlen, Daniel Matthias Aebersold, Robert Foerster, Mohamed Shelan
Five Fractions versus Seven Fractions SBRT for Intermediate- and High-Risk Prostate Cancer: A Propensity Score Matched Pair Analysis. Cancers 15 (24) (2023)
Christina Schröder, Lucas Mose, Etienne Mathier, Daniel Rudolf Zwahlen, Daniel Matthias Aebersold, Robert Foerster, Mohamed Shelan
Five Fractions versus Seven Fractions SBRT for Intermediate- and High-Risk Prostate Cancer: A Propensity Score Matched Pair Analysis. Cancers 15 (24) (2023)
Christina Schröder, Lucas Mose, Etienne Mathier, Daniel Rudolf Zwahlen, Daniel Matthias Aebersold, Robert Foerster, Mohamed Shelan
Five Fractions versus Seven Fractions SBRT for Intermediate- and High-Risk Prostate Cancer: A Propensity Score Matched Pair Analysis. Cancers 15 (24) (2023)